Company
date founded
Financing round
General
About Company
Abceutics operates as a biopharmaceutical company.
IPO status
Private
Contacts
Website URL
M&A Details1
Transaction name
Acquired by
Merck Sharp & Dohme Sweden AB
announced date
05.04.2024
price
$208M